Microglial heparan sulfate in the modulation of APOE function and neurodegeneration
小胶质细胞硫酸乙酰肝素调节 APOE 功能和神经退行性变
基本信息
- 批准号:10555329
- 负责人:
- 金额:$ 58.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:ATP binding cassette transporter 1AblationAffinityAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAmyloid depositionAnimalsApolipoprotein EAttentionBehavioralBindingBinding ProteinsBrainBrain PathologyCell surfaceChargeCholesterolCodeCore ProteinDataDementiaDevelopmentExcisionExhibitsExtracellular MatrixGenesGeneticGenetic PolymorphismGenetic RiskGenomicsGoalsHeparan Sulfate ProteoglycanHeparinHeparitin SulfateHeparitin sulfotransferaseHumanHuman GeneticsImmunomodulatorsImpaired cognitionIn VitroLate Onset Alzheimer DiseaseLigandsLinkLipidsMaintenanceMediatingMedicalMicrogliaMolecularMusMutant Strains MiceMutationNerve DegenerationNeuronsPathway interactionsPhenotypePlayPolysaccharidesProcessProtein IsoformsProteinsRecurrent diseaseRegulationRelative RisksReportingResearchResearch PriorityResistanceRiskRisk FactorsRoleSenile PlaquesSeriesSignal TransductionSulfateSurfaceSynapsesTREM2 geneVariantWomanapolipoprotein E-3apolipoprotein E-4cationic antimicrobial protein CAP 37cholesterol transportersexperimental studyfunctional genomicsgenetic associationgenetic risk factorgenomic dataglial activationglycosylationimmunoregulationin vivoinsightmouse modelneuroinflammationnovelpresenilin-1receptorresponsesugartau Proteinstherapeutic target
项目摘要
Heparan sulfate (HS), a sulfated glycan expressed at the cell surface and in extracellular matrix, has long
attracted attention as a putative factor involved in Alzheimer's disease (AD), based on circumstantial
evidence from in vitro and clinicopathological studies. Nevertheless, the functional significance of HS in
AD, especially in the late-onset type (LOAD) that comprises more than 90% of AD cases, is elusive. Recent
human genomic studies implicate ApoE and microglia as dominant contributors to neurodegeneration in
LOAD. The APOE gene is the strongest known genetic risk factor for LOAD. Accumulating data indicate
that ApoE proteins exert immunomodulatory effects on microglia, and that this function of ApoE is at least
partly mediated by the TREM2 receptor, another AD risk factor that is expressed by microglia. Among the
three human APOE alleles, the APOE4 allele confers an increased risk for LOAD, while the APOE2 allele
confers a decreased risk relative to the more common APOE3 allele. The molecular basis of these allele-
specific risk variations is one of the key unanswered issues in AD research. In this context, it is interesting
to note that ApoE proteins bind HS in an isoform-specific manner — ApoE4 exhibits 2- to 3-fold greater
affinity for HS than ApoE2 and ApoE3, thus apparently correlating with their relative AD risks. Furthermore,
a recent report regarding the unique case of a Columbian woman, who carries a highly detrimental
PSEN1E280A mutation, suggests that her APOE3 "Christchurch" mutation, which abolishes the affinity of
ApoE3 for HS, confers strong protection against neurodegeneration and cognitive impairment. Also
suggesting the functional involvement of HS in LOAD are recurrent reports of genetic association of HS
sulfotransferase genes with LOAD. In a series of preliminary studies, we have obtained multiple pieces of
evidence suggesting that the strong interaction of HS with ApoE4, relative to its interactions with ApoE2
and ApoE3, is the key underlying mechanism by which ApoE4 exerts a detrimental effect on the brain.
Significantly, we have found that haploinsufficient reduction in HS expression leads to the mitigation of
synapse loss and microglial activation in the PS19 TauP310S mouse model. We hypothesize that HS plays
a critical role in mediating the ApoE4 effect on microglial response and function, and that the detrimental
effect of the APOE4 allele is mainly due to its stronger interaction with the 3-O sulfate-rich HS species
expressed in microglia. We will: (1) determine the role of HS in ApoE-TREM2 interaction and signaling in
microglia; (2) determine the role of microglial HS in ApoE/ABCA1-mediated cholesterol efflux; and (3)
examine in vivo effects of microglial HS on brain pathology and function in AD mouse models. This
research will provide entirely novel insights into the role of HS in microglia, and moreover, into long-term
questions regarding the isoform-specific risk of APOE variants. Successful completion of this project will
reveal the ApoE4-HS interaction as a promising therapeutic target for reducing AD risk in APOE4 carriers.
硫酸乙酰肝素(HS)是一种表达在细胞表面和细胞外基质中的硫化多糖,具有很长的
根据间接证据,作为阿尔茨海默病(AD)的推定因素引起了人们的注意
来自体外和临床病理研究的证据。尽管如此,HS在中国的功能意义
AD,特别是占AD病例90%以上的晚发型(LOAD),是难以捉摸的。近期
人类基因组研究表明载脂蛋白E和小胶质细胞是神经变性的主要贡献者
装填。载脂蛋白E基因是已知的最强的负荷遗传风险因素。累积的数据表明
ApoE蛋白对小胶质细胞具有免疫调节作用,并且ApoE的这种作用至少是
部分由TREM2受体介导,这是另一个由小胶质细胞表达的AD危险因子。在这些人中
人类的三个载脂蛋白E等位基因中,载脂蛋白4等位基因增加了负荷风险,而载脂蛋白2等位基因
与更常见的APOE3等位基因相比,风险降低。这些等位基因的分子基础-
具体的风险变异是AD研究中尚未回答的关键问题之一。在这种情况下,有趣的是
要注意的是,ApoE蛋白以一种异构体特异性的方式结合HS-ApoE4表现出2-3倍的
对HS的亲和力高于APOE2和ApoE3,因此明显与他们的相对AD风险相关。此外,
最近关于一名哥伦比亚妇女的独特病例的报道,她携带了一种非常有害的
PSEN1E280A突变,表明她的APOE3“克赖斯特彻奇”突变,这取消了亲和力
APOE3对于HS,提供强大的保护,防止神经退化和认知障碍。也是
提示HS在LOAD中的功能参与是HS基因关联的反复报道
磺基转移酶基因的负载量。在一系列初步研究中,我们获得了多件
证据表明,HS与ApoE4的强相互作用,相对于其与APOE2的相互作用
和ApoE3,是ApoE4对大脑产生有害影响的关键潜在机制。
值得注意的是,我们发现HS表达的单倍体不足减少导致了
PS19TauP310S小鼠模型中突触丢失和小胶质细胞激活。我们假设HS会玩
在调节载脂蛋白E4对小胶质细胞反应和功能的影响中起着关键作用,而有害的
APOE4等位基因的作用主要是由于它与富含3-O硫酸盐的HS物种有更强的相互作用
表达于小胶质细胞。我们将:(1)确定HS在ApoE-TREM2相互作用和信号转导中的作用
小胶质细胞;(2)确定小胶质细胞HS在ApoE/ABCA1介导的胆固醇外流中的作用;以及(3)
观察小胶质细胞HS对AD模型小鼠脑病理和脑功能的影响。这
研究将为HS在小胶质细胞中的作用提供全新的见解,而且还将提供长期的
关于载脂蛋白E变异体的异构体特定风险的问题。这个项目的成功完成将
揭示ApoE4-HS相互作用是降低APOE4携带者AD风险的有前景的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YU YAMAGUCHI其他文献
YU YAMAGUCHI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YU YAMAGUCHI', 18)}}的其他基金
Microglial heparan sulfate in the modulation of APOE function and neurodegeneration
小胶质细胞硫酸乙酰肝素调节 APOE 功能和神经退行性变
- 批准号:
10370905 - 财政年份:2022
- 资助金额:
$ 58.1万 - 项目类别:
Heparan sulfate in neurophysiology and neurological disorders
硫酸乙酰肝素在神经生理学和神经系统疾病中的作用
- 批准号:
8965407 - 财政年份:2015
- 资助金额:
$ 58.1万 - 项目类别:
Heparan sulfate in neurophysiology and neurological disorders
硫酸乙酰肝素在神经生理学和神经系统疾病中的作用
- 批准号:
9105755 - 财政年份:2015
- 资助金额:
$ 58.1万 - 项目类别:
Genetic dissection of the role of chondroitin sulfate in cartilage
硫酸软骨素在软骨中作用的基因解析
- 批准号:
8440194 - 财政年份:2012
- 资助金额:
$ 58.1万 - 项目类别:
Genetic dissection of the role of chondroitin sulfate in cartilage
硫酸软骨素在软骨中作用的基因剖析
- 批准号:
8716529 - 财政年份:2012
- 资助金额:
$ 58.1万 - 项目类别:
Genetic dissection of the role of chondroitin sulfate in cartilage
硫酸软骨素在软骨中作用的基因解析
- 批准号:
8543628 - 财政年份:2012
- 资助金额:
$ 58.1万 - 项目类别:
Genetic dissection of the role of chondroitin sulfate in cartilage
硫酸软骨素在软骨中作用的基因剖析
- 批准号:
8898723 - 财政年份:2012
- 资助金额:
$ 58.1万 - 项目类别:
Heparan Sulfate in Schwann Cell Development and Myelination
硫酸乙酰肝素在雪旺细胞发育和髓鞘形成中的作用
- 批准号:
8185308 - 财政年份:2010
- 资助金额:
$ 58.1万 - 项目类别:
Heparan Sulfate in Skeletal Development and Diseases
硫酸乙酰肝素在骨骼发育和疾病中的作用
- 批准号:
7812498 - 财政年份:2009
- 资助金额:
$ 58.1万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 58.1万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 58.1万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 58.1万 - 项目类别:
Standard Grant














{{item.name}}会员




